Jiangsu Recbio Technology Co., Ltd. (2179.HK)
HKD 8.0
(2.56%)
HKD 8.0
(2.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.18 Billion CNY | -5.34% |
| 2022 | 2.3 Billion CNY | 20.34% |
| 2021 | 1.91 Billion CNY | 83.3% |
| 2020 | 1.04 Billion CNY | 145.46% |
| 2019 | 426.54 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.05 Billion CNY | 0.0% |
| 2024 Q1 | 2.05 Billion CNY | -5.83% |
| 2023 Q1 | 2.24 Billion CNY | -2.79% |
| 2023 FY | 2.18 Billion CNY | -5.34% |
| 2023 Q4 | 2.18 Billion CNY | 0.0% |
| 2023 Q3 | 2.18 Billion CNY | -2.63% |
| 2023 Q2 | 2.24 Billion CNY | 0.0% |
| 2022 Q2 | 2.41 Billion CNY | 0.0% |
| 2022 Q1 | 2.41 Billion CNY | 25.69% |
| 2022 FY | 2.3 Billion CNY | 20.34% |
| 2022 Q4 | 2.3 Billion CNY | 0.0% |
| 2022 Q3 | 2.3 Billion CNY | -4.26% |
| 2021 Q4 | 1.91 Billion CNY | -3.87% |
| 2021 FY | 1.91 Billion CNY | 83.3% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q3 | 1.99 Billion CNY | 0.0% |
| 2020 Q4 | 1.04 Billion CNY | 0.0% |
| 2020 FY | 1.04 Billion CNY | 145.46% |
| 2019 FY | 426.54 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -433.249% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 80.562% |